Approaches to restoring and maintaining normal sinus rhythm

Cleveland Clinic Journal of Medicine

Volumn 70, Issue SUPPL. 3, 2003, Pages

  Martin, David O ^a,b   Saliba, Walid ^a,b   McCarthy, Patrick M ^a,b   Gillinov, A Marc ^a   Belden, William ^a   Marrouche, Nassir F ^a   Natale, Andrea ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Mail Code F15   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; MORACIZINE; POTASSIUM CHANNEL BLOCKING AGENT; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; ANTIARRHYTHMIC AGENT;

DRUG CLASSIFICATION; HEART ATRIUM FIBRILLATION; HUMAN; REVIEW; SINUS RHYTHM; CATHETER ABLATION; CLASSIFICATION; DRUG EFFECT; HEART PACING; HEART RATE; METHODOLOGY;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; HEART RATE; HUMANS;

EID: 0042570403     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.suppl_3.s12     Document Type: Review

References (71)

1. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342:913-920.
2. Stanton M. Class I antiarrhythmic drugs. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 3rd ed. Philadelphia: WB Saunders; 2000:890-903.
3. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis. Circulation 1990; 82:1106-1116.
4. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406-412.
5. Nattel S. Class III drugs. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 3rd ed. Philadelphia: WB Saunders; 2000:921-932.
6. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348:7-12.
7. Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000; 102:2385-2390.
8. Greenbaum R, Campbell TJ, Channer KS, et al. Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide: the EMERALD study. Circulation 1998; 98(suppl I):I-633. Abstract.
9. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. DIAMOND Study Group. N Engl J Med 1999; 341:857-665.
10. Kober L, Bloch-Thomsen PE, Moller M, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000; 356:2052-2058.
11. Stambler BS, Wood MA, Ellenbogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94:1613-1621.
12. Lamas GA, Lee KL, Sweeney MO, et al, for the MODE Selection Trial. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-1862.
13. Skanes AC, Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol 2001; 38:167-172.
14. Gillis AM, Kerr CR. Whither physiologic pacing? Implications of CTOPP. Pacing Clin Electrophysiol 2000; 23:1193-1196.
15. Gillis AM, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999; 99:2553-2558.
16. Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The PA (3) study investigators. Circulation 2000; 102:736-741.
17. Hotline Sessions of the 23rd European Congress of Cardiology. Eur Heart J 2001; 22:2033-2037.
18. Padeletti L, Purerfellner H, Adler S, et al. Atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial fibrillation: ASPECT study results. Pacing Clin Electrophysiol 2002; 25(4 Pt II):687. Abstract 659.
19. Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12:912-917.
20. Kale M, Bennett DH. Atrial septal pacing in the prevention of paroxysmal atrial fibrillation refractory to antiarrhythmic drugs. Int J Cardiol 2002; 82:167-175.
21. El Allaf D, et al. Low atrial septum pacing and dynamic atrial overdrive to lower AF burden. Europace 2001; 2(suppl):B38. Abstract.
22. Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40:1140-1152.
23. Ramdat Misier AR, Beukema WP, Oude Luttikhuis HA, et al. Multisite atrial pacing: an option for atrial fibrillation prevention? Preliminary results of the Dutch dual-site right atrial pacing for prevention of atrial fibrillation study. Am J Cardiol 2000; 86(9 Suppl 1):K20-K24.
24. Mirza I, James S, Holt P. Biatrial pacing for paroxysmal atrial fibrillation: a randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardiol 2002; 40:457-463.
25. Padeletti L, Pieragnoli P, Ciapetti C, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001; 142:1047-1055.
26. Israel CW, Hugl B, Unterberg C, et al, for the AT500 Verification Study. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12:1121-1128.
27. Carlson MD, Gold MR, Ip J, et al. Dynamic atrial overdrive pacing decreases symptomatic atrial arrhythmia burden in patients with sinus node dysfunction. Circulation 2001; 104(suppl):II-383. Abstract 1825.
28. Lee MA, Weachter R, Pollak S, et al. Can preventive and antitachycardia pacing reduce the frequency and burden of atrial tachyarrhythmias? The ATTEST study results. Pacing Clin Electrophysiol 2002; 25(4 Pt II):541. Abstract 74.
29. Seidl K, Cazeau S, Gaita F, et al. Dual-site pacing vs mono-site pacing in prevention of atrial fibrillation. Pacing Clin Electrophysiol 2002; 24(4 Pt II):568. Abstract 184.
30. Vollmann D, Moeller C, Stevens J, et al. Automatic 50-Hz burst pacing for the termination of atrial fibrillation: manual success analysis in patients with intermittent atrial tachyarrhythmias in a novel dual-chamber ICD. Circulation 2001; 104(suppl II):II-384. Abstract 1829.
31. Daoud EG, Timmermans C, Fellows C, et al. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Circulation 2000; 102:1407-1413.
32. Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000; 101:1138-1144.
33. Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344:1043-1051.
34. Cox JL, Ad N, Palazzo T, et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000; 12:15-19.
35. McCarthy PM, Gillinov AM, Castle L, et al. The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:25-29.
36. Lonnerholm S, Blomstrom P, Nilsson L, et al. Effects of the Maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000; 101:2607-2611.
37. Cox JL, Ad N, Palazzo T. Impact of the Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118:833-840.
38. Gillinov AM, Pettersson G, Rice TW. Esophageal injury during radiofrequency ablation for atrial fibrillation. J Thorac Cardiovasc Surg 2001; 122:1239-1240.
39. Schaff HV, Dearani JA, Daly RC, et al. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:25-29.
40. Arcidi JM Jr, Doty DB, Millar RC. The Maze procedure: the LDS Hospital experience. Semin Thorac Cardiovasc Surg 2000; 12:38-43.
41. Haisaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-666.
42. Gillinov AM, McCarthy PM. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 2002; 74:2165-2168.
43. Quader MA, McCarthy PM, Gillinov AM, et al. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg. In press.
44. Prasad SM, Maniar HS, Schuessler RB, et al. Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg 2002; 124:708-713.
45. Haissaguerre M, Jais P, Shah DC, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996; 7:1132-1144.
46. Ernst S, Schluter M, Ouyang F, et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 1999; 100:2085-2092.
47. Shah DC, Haissaguerre M, Jais P. Current perspectives on curative catheter ablation of atrial fibrillation. Heart 2002; 87:6-8.
48. Chen SA, Tai CT, Tsai CF, et al. Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats. J Cardiovasc Electrophysiol 2000; 11:218-227.
49. Haissaguerre M, Jais P, Shah DC, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101:1409-1417.
50. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107:2710-2716.
51. Marrouche NF, Dresing T, Cole C, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 2002; 40:464-474.
52. Ng FS, Camm AJ. Catheter ablation of atrial fibrillation. Clin Cardiol 2002; 25:384-394.
53. Kanagaratnam L, Tomassoni G, Schweikert R, et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing Clin Electrophysiol 2001; 24:1774-1779.
54. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation. Circulation 2001; 104:2539-2544-
55. Natale A, Pisano E, Shewchik J, et al. First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 2000; 102:1879-1882.
56. Saliba W, Wilber D, Packer D, et al. Circumferential ultrasound ablation for pulmonary vein isolation: analysis of acute and chronic failures. J Cardiovasc Electrophysiol 2002; 13:957-961.
57. Cooper JM, Epstein LM. Use of intracardiac echocardiography to guide ablation of atrial fibrillation. Circulation 2001; 104:3010-3013.
58. Chen MS, Marrouche N, et al. Pulmonary vein isolation for treatment of atrial fibrillation in patients with impaired systolic function. Presented at: annual meeting of the American College of Cardiology; March 2002; Atlanta. Abstract.
59. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999;100:1879-1886.
60. Gerstenfeld EP, Guerra P, Sparks PB, et al. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001; 12:900-908.
61. Sanders P, Morton JB, Deen VR, et al. Immediate and long-term results of radiofrequency ablation of pulmonary vein ectopy for cure of paroxysmal atrial fibrillation using a focal approach. Intern Med J 2002; 32:202-207.
62. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000; 102:2619-2628.
63. Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102:2463-2465.
64. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105:1077-1081.
65. Mangrum JM, Mounsey JP, Kok LC, et al. Intracardiac echocardiography- guided, anatomically based radiofrequency ablation of focal atrial fibrillation originating from pulmonary veins. J Am Coll Cardiol 2002; 39:1964-1972.
66. Oral H, Knight BP, Ozaydin M, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation 2002; 106:1256-1262.
67. Macle L, Jais P, Weerasooriya R, et al. Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2002; 13:1067-1073.
68. Deisenhofer I, Schneider MA, Bohlen-Knauf M, et al. Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am J Cardiol 2003; 91:159-163.
69. Robbins IM, Colvin EV, Doyle TP, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 1998; 98:1769-1775.
70. Yu W, Hsu T, Tai C, et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2001; 12:887-892.
71. Wu RC, Brinker JA, Yuh DD, et al. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol 2002; 13:819-821.